LSDPsilocybin

Improved colour blindness symptoms associated with recreational psychedelic use: Results from the Global Drug Survey 2017

Analysis of self-reports from the Global Drugs Survey 2017 found that 23 of 47 usable respondents described improved colour blindness after using psychedelics (commonly LSD and psilocybin), with some changes persisting from days to years. The authors present this as preliminary evidence and suggest a mechanism in which psychedelic-induced novel photisms become linked to pre-existing colour concepts via enhanced visual–linguistic cortical connectivity, recommending targeted follow-up studies.

Authors

  • David Nutt
  • Jason Ferris

Published

Drug Science Policy and Law
individual Study

Abstract

It is well documented that psychedelic drugs can have a profound effect on colour perception. After previous research involving psychedelic drug ingestion, several participants had written to the authors describing how symptoms of their colour blindness had improved. The Global Drugs Survey runs the world’s largest annual online drug survey. In the Global Drugs Survey 2017, participants reporting the use of lysergic acid diethylamide or psilocybin in the last 12 months were asked, We have received reports from some people with colour-blindness that this improves after they use psychedelics. If you have experienced such an effect can you please describe it in the box below, say what drug you took and how long the effect lasted. We received 47 responses that could be usefully categorised of which 23 described improved colour blindness. Commonly cited drugs were LSD and psilocybin; however, several other psychedelic compounds were also listed. Some respondents cited that the changes in colour blindness persisted, from a period of several days to years. Improved colour blindness may be a result of new photisms experienced in the psychedelic state aligning with pre-existing concepts of colour to be ascribed a label. Connections between visual and linguistic cortical areas may be enhanced due to disorder in the brain’s neural connections induced by psychedelics allowing these new photisms and concepts to become linked. This paper provides preliminary data regarding improved colour blindness accompanying recreational psychedelic use which may be further investigated in future iterations of the Global Drugs Survey or in a stand-alone Global Drugs Survey-managed psychedelics survey.

Available with Blossom Pro

Research Summary of 'Improved colour blindness symptoms associated with recreational psychedelic use: Results from the Global Drug Survey 2017'

Introduction

Historical and laboratory literature describes profound alterations to colour perception produced by psychedelic drugs, including changes to spectral patterns and hue discrimination. Such reports challenge simple models that treat colour vision as determined solely by retinal photoreceptors, because central processing can alter the experienced colour without changing retinal input. The authors also note anecdotal reports from prior research participants and online forums claiming that psychedelic use produced improvements in previously congenital colour-blind perception. Anthony and colleagues set out to collect preliminary, population-level data on whether recreational psychedelic use is associated with perceived improvements in colour blindness. Rather than a mechanistic experiment, the study used an exploratory item added to the Global Drug Survey 2017 to gather self-reported accounts about whether people who reported recent LSD or psilocybin use had experienced an improvement in their ability to distinguish colours and how long any change lasted. The stated aim was to assess whether this phenomenon occurs frequently enough to merit more detailed follow-up studies or a dedicated survey module.

Expert Research Summaries

Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.

Full Text PDF

Full Paper PDF

Create a free account to open full-text PDFs.

Study Details

  • Study Type
    individual
  • Journal
  • Compounds
  • Authors
  • APA Citation

    Anthony, J., Winstock, A., Ferris, J., & Nutt, D. (2020). Improved colour blindness symptoms associated with recreational psychedelic use: Results from the Global Drug Survey 2017. Drug Science, Policy and Law, 6. https://doi.org/10.1177/2050324520942345

References (10)

Papers cited by this study that are also in Blossom

Serotonergic psychedelics and personality: A systematic review of contemporary research

Bouso, J. C., Dos Santos, R. G., Hallak, J. E. · Neuroscience and Biobehavioral Reviews (2018)

The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs

Carhart-Harris, R. L., Leech, R., Shanahan, M. et al. · Frontiers in Human Neuroscience (2014)

Serotonin and brain function: a tale of two receptors

Carhart-Harris, R. L., Nutt, D. J. · Journal of Psychopharmacology (2017)

LSD acutely impairs fear recognition and enhances emotional empathy and sociality

Dolder, P. C., Schmid, Y., Müller, F. et al. · Neuropsychopharmacology (2016)

The induction of synaesthesia with chemical agents: a systematic review

Luke, D. P., Terhune, D. B. · Frontiers in Psychology (2013)

Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels

Madsen, M. K., Fisher, P. M., Burmester, D. et al. · Neuropsychopharmacology (2019)

Hallucinogen Persisting Perception Disorder: Etiology, Clinical Features, and Therapeutic Perspectives

Martinotti, G., Santacroce, R., Pettorruso, M. et al. · Brain Sciences (2018)

Psychedelics and the human receptorome

Ray, T. S. · PLOS ONE (2010)

265 cited
Serotonergic hallucinogens and recognition of facial emotion expressions: a systematic review of the literature.

Rocha, J. M., Osório, F. L., Crippa, J. A. et al. · Therapeutic Advances in Psychopharmacology (2019)

Increased amygdala responses to emotional faces after psilocybin for treatment-resistant depression

Roseman, L., Demetriou, L., Wall, M. B. et al. · Neuropharmacology (2018)

Cited By (4)

Papers in Blossom that reference this study

Three Cases of Reported Improvement in Microsmia and Anosmia Following Naturalistic Use of Psilocybin and LSD

Kovacevich, A., Weleff, J., Claytor, B. et al. · Journal of Psychoactive Drugs (2023)

5 cited
Case report: Prolonged amelioration of mild red-green color vision deficiency following psilocybin mushroom use

Barnett, B. S., Sweat, N. W., Hendricks, P. S. · Drug Science Policy and Law (2023)

4 cited
Investigation of self-treatment with lysergic acid diethylamide and psilocybin mushrooms: Findings from the Global Drug Survey 2020

Kopra, E., Ferris, J. A., Winstock, A. R. et al. · Journal of Psychopharmacology (2023)

Magic Mushroom Use: A Qualitative Interview Study of Post-Trip Impacts and Strategies for Optimizing Experiences

Shaw, L., Rea, K., Lachowsky, N. J. et al. · Journal of Psychoactive Drugs (2022)

11 cited

Your Personal Research Library

Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.